Combined training does not provide additional benefits or show improvements in fitness in younger subjects compared with aerobic and resistance training alone. In older subjects, there was a trend to greater aerobic fitness gains with aerobic + resistance versus aerobic alone….
Read More »Calcium Supplements Boost Heart-Attack Risk: Meta-Analysis
The use of calcium supplements without coadministered vitamin D is associated with an increased risk of MI. The finding, from a meta-analysis encompassing 15 randomized trials and up to 11,921 participants, warrants a reassessment of the role of calcium supplements in the management of osteoporosis, researchers report…
Read More »Study Questions Aggressive Glucose Control in All Patients with Diabetes and Renal Failure
Aggressive glucose control does not improve survival in patients with diabetes and renal failure, according to a study. The results suggest that physicians should individualize hemoglobin (Hb) A1c targets for these patients and not rely on recommendations based on studies in the general population…
Read More »Shorter (5-mm) Needles Deliver Insulin Reliably
New research has found that 5-mm needles effectively deliver insulin into subcutaneous fat in both adults and children. Compared with intramuscular injections of insulin, injections into the subcutaneous fat are associated with less variability in glycemic control as well as a lower risk for hypoglycemia…
Read More »Diabetes Patients Medical Treatments Cost Hospitals $83 Billion
Hospitals spent $83 billion in 2008 caring for people with diabetes with one out of every five hospitalizations being a person that has diabetes. This was according to a report prepared by the Healthcare Research and Quality Agency (AHRQ)…
Read More »New Nutritional Scoring System: NuVal Rating
Consumers’ growing demand for nutritional guidance spurred the creation of NuVal. NuVal’s labeling system evaluates foods based upon more than 30 nutritional attributes, including positive ones such as fiber and negative ones such as saturated fat. It uses a mathematical formula to assign products a score on a scale of …
Read More »Interview with Dr. Lou Vaickus, Tolerx, Question 7
DJ: What is the anticipated timeline for commercialization if all goes well?
Read More »Interview with Dr. Lou Vaickus, Tolerx, Question 6
DJ: Will there be any application of this drug class for Type 2 diabetes?
Read More »Interview with Dr. Lou Vaickus, Tolerx, Question 5
DJ: What kind of results have you seen so far?
Read More »Interview with Dr. Lou Vaickus, Tolerx, Question 4
DJ: What distinguishes otelixizumab from other drugs in its class?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.